首页> 外文OA文献 >Rapid Simultaneous Determination of Telmisartan, Amlodipine Besylate and Hydrochlorothiazide in a Combined Poly Pill Dosage Form by Stability-Indicating Ultra Performance Liquid Chromatography
【2h】

Rapid Simultaneous Determination of Telmisartan, Amlodipine Besylate and Hydrochlorothiazide in a Combined Poly Pill Dosage Form by Stability-Indicating Ultra Performance Liquid Chromatography

机译:稳定性指示超高效液相色谱法快速同时测定多药组合剂型中的替米沙坦,苯磺酸氨氯地平和氢氯噻嗪

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A simple, precise and rapid stability-indicating ultra-performance liquid chromatography (UPLC) method is developed for the simultaneous quantitative determination of Telmisartan, Amlodipine besylate and Hydrochlorothiazide from their innovative poly pill combination drug product in the presence of degradation products. It involves a 100 mm x 2.1 mm, 1.7 μm C-18 column. The separation is achieved on a simple gradient method. The mobile phase A contains a mixture of sodium perchlorate buffer pH 3.2 (0.053M): acetonitrile in the ratio 90:10, v/v, and mobile B contains a mixture of sodium perchlorate buffer pH 3.2 (0.053M): acetonitrile in the ratio 20:80, v/v. The flow rate is 0.6 mL min−1 and the column temperature is maintained at 55°C.The gradient program (T/%B) is set as 0/5, 1.2/5, 1.6/40, 4/40, 4.1/5 and 4.5/5. The detector wavelength is 271 nm for Hydrochlorothiazide and Telmisartan and 237 nm for Amlodipine. The retention times of Telmisartan, Amlodipine, and Hydrochlorothiazide are 3.6 minutes, 3.2 minutes and 0.9 minutes; respectively. The total runtime for the separation of the three active compounds and their degradation products is 4.5 minutes. The described method is validated with respect to system suitability, specificity, linearity, precision and accuracy. The precision of the assay method is evaluated by carrying out six independent assays of T, A and H (0.032 mg mL−1 of T, 0.004 mg mL−1 of A, 0.01 mg mL−1 of H). The accuracy of the method is evaluated in triplicate at three concentration levels, i.e. 50%, 100% and 150% of target test concentration (0.64 mg mL−1 of T, 0.08 mg mL−1 of A, 0.2 mg mL−1 of H). The described method is linear over the range, 16 to 48 μg mL−1 for T, 2 to 6 μg mL−1A and 5 to 15 μg mL−1 for H. The method is fast and suitable for high-throughput analysis allowing the analysis of about 250 samples per working day.
机译:建立了一种简单,精确和快速的稳定性指示超高效液相色谱(UPLC)方法,用于在降解产物存在的情况下,从其创新的多药丸组合药物产品中同时定量测定替米沙坦,苯磺酸氨氯地平和氢氯噻嗪。它涉及100 mm x 2.1 mm,1.7μm的C-18色谱柱。分离是通过简单的梯度方法实现的。流动相A含有比例为90:10,v / v的高氯酸钠缓冲液pH 3.2(0.053M):乙腈的混合物,而流动相B则含有pH 3.2的高氯酸钠缓冲液(0.053M):乙腈的混合物比率20:80,v / v。流速为0.6 mL min-1,柱温保持在55°C。梯度程序(T /%B)设置为0 / 5、1.2 / 5、1.6 / 40、4 / 40、4.1 / 5和4.5 / 5。氢氯噻嗪和替米沙坦的检测器波长为271 nm,氨氯地平的检测器波长为237 nm。替米沙坦,氨氯地平和氢氯噻嗪的保留时间分别为3.6分钟,3.2分钟和0.9分钟;分别。分离三种活性化合物及其降解产物的总运行时间为4.5分钟。相对于系统适用性,特异性,线性,精确度和准确性验证了所描述的方法。通过对T,A和H(0.032 mg mL-1的T,0.004 mg mL-1的A,0.01 mg mL-1的H)进行六个独立的测定,可以评估测定方法的精度。在三个浓度水平(即目标测试浓度的50%,100%和150%)(T的0.64 mg mL-1,A的0.08 mg mL-1、0.2 mg的mL-1)的三个浓度水平下,一式三份地评估方法的准确性。 H)。所描述的方法在以下范围内是线性的:对于T为16至48μgmL-1,对于H为2至6μgmL-1A,对于H为5至15μgmL-1。该方法快速且适用于高通量分析,允许每个工作日分析约250个样品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号